@article {1383, title = {Comparative Pharmacognostical, Phytochemical and Biological Evaluation of Five Ocimum Species}, journal = {Pharmacognosy Journal}, volume = {13}, year = {2021}, month = {March 2021}, pages = {463-474}, type = {Research Article}, chapter = {463}, abstract = {

There are about 150 species of Ocimum in the world and out of that 68 species are found in India. Comparative pharmacognostic study of these Ocimum species is unspecified. Growing demand of Ocimum plants demands quality standards for correct identification of desired Ocimum species. Objectives: Hence aim of present study is to establish comparative pharmacognostical, phytochemical and biological standards for most commonly found and morphologically confusing five species of Ocimum. Methods: Macroscopic, microscopic, preliminary phytochemical evaluations, extraction of essential oils, TLC analysis, in vitro antioxidant and antimicrobial potency of selected five species carried out and compared. Results: This comparative study reports that O. sanctum should be preferred in medicine use among selected five species based on phytochemical composition, antioxidant and antimicrobial potency.

}, keywords = {Ocimum americanum, Ocimum basilicum, Ocimum gratissimum, Ocimum kilimandscharicum, Ocimum sanctum}, doi = {10.5530/pj.2021.13.59}, author = {Sharada L Deore and Shital R Ingole and Bhushan A Baviskar and Anjali A kide} } @article {1112, title = {Correlation between the in-vitro and in-vivo Antihyperglycemic Effect of Ocimum Sanctum, Trigonella Foenum Graecum and Curcuma Longa}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {March 2020}, pages = {369-376}, type = {Research Article}, chapter = {369}, abstract = {

This study is carried out to investigate the correlation between the in-vitro and in-vivo studies which demonstrates the antihyperglycemic effect of Trigonella foenum graecum, Ocimum sanctum and Curcuma longa extracts. Methanolic seed extract of Trigonella foenum graecum, methanolic leaf extract of Ocimum sanctum, ethyl acetate rhizomes extract of Curcumina longa are prepared and supplied by Sami labs, Bangalore, India on request. in-vitro studies such as alpha glucosidase inhibitory and DPP-IV inhibitory activity were done for all the three extracts as per previous studies. After Institutional animal ethical committee clearance male albino rats (155{\textendash}215 g) were divided into 5 groups. Each group consists of randomly assigned 6 albino rats. The placebo (Normal saline) control group, Standard (Vildagliptin) group and 3 above mentioned extract groups. Oral glucose tolerance test (OGTT) was done. Blood samples were collected for blood sugar estimation at -30 (before extract),0, 15, 45 minutes and blood sugar levels were done by enzymatic assay. Results: The maximum alpha-glucosidase inhibitory activity at 100 μg/ml by Trigonella foenum graecum extract was 68\% with IC50 value of 57.25, Ocimum sanctum leaf extract was 65\% with IC50 value of 59.55, Curcuma longa was 72\% with IC50 value of 56.79 when compared to the Acarbose (STD) of 94\% with IC50 values of 42.78. The maximum \% of DPP IV inhibition at 320 μg/ml of Trigonella foenum graecum extract was 77.84\% with IC50 value of 52.26, Ocimum sanctum extract was 86.98\% with IC50 value of 46.08 and Curcuma longa was 76.47\% with IC50 value of 55.06 when compared to the Vildagliptin (STD) was 80.15\% with IC50 value of 22.98. The OGTT results of Ocimum sanctum (200 mg/kg) shows reduction in blood glucose (p=\<0.05) at 15 minutes and significant reduction (p=\<0.001) at 45 minutes and Trigonella foenum graecum (2 gm/kg) showed significant reduction in blood glucose (p=\<0.001) at 15 minutes when compared to control. Further clinical studies are necessary to establish the therapeutic potential of these extracts in the treatment of type 2 diabetes mellitus. Conclusion: Ocimum sanctum leaf extract, Trigonella foenum graecum seed extract shows significant alpha-glucosidase and DPPIV inhibitory activity which correlates with the antihyperglycemic effects by in-vivo oral glucose tolerance test. Further clinical studies are necessary to establish the therapeutic potential of these extracts in the treatment of type 2 diabetes mellitus.

}, keywords = {Curcuma longa, GLP-1, Glucagon, Insulin, Ocimum sanctum, Trigonella foenum graecum, Type 2 diabetes mellitus}, doi = {10.5530/pj.2020.12.58}, author = {Inbaraj SD and Muniappan M} } @article {1217, title = {Ocimum sanctum: Role in Diseases Management Through Modulating Various Biological Activity }, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {August 2020}, pages = {1198-1205 }, type = {Review Article}, chapter = { 1198}, abstract = {

Medicinal plants are used commonly by traditional medical practitioners in their daily practice for the treatment of various diseases. The treatment based on natural products are preferred because they are more economic and have lesser side-effects. In this regards, Ocimum sanctum commonly known as holy basil or tulsi is used in the diseases cure and treatment since ancient time. Ocimum sanctum has been proven health promoting effect through modulation of various biological activates. Ocimum sanctum shows therapeutic role through its anti-oxidant, anti-inflammatory, anti-microbial, anti-diabetic, hepatoprotective and wound healing effects. Besides, the constituents of holy basil have been confirmed to have a noteworthy effect in cancer management through inhibition of cancer development and progression. Further, the synergistic effect of Ocimum sanctum component with anti-cancer drugs has been proven as it reduces the growth of cancer. Molecular mechanism and human clinical trials based should be performed to avail its role in diseases cure and management. This review comprehensively summarizes the role of holy basil in disease management through in vivo and in vitro study.

}, keywords = {Anti-cancer, Anti-oxidant effect, Health promoting effect, Ocimum sanctum}, doi = {10.5530/pj.2020.12.168 }, author = {Saleh A Almatroodi and Mohammed A Alsahli and Ahmad Almatroudi and Arshad Husain Rahmani} } @article {986, title = {Effect of Ocimum sanctum Leaf Extract on Entero-Insular Axis by Oral Glucose Tolerance Test in Albino Rats}, journal = {Pharmacognosy Journal}, volume = {11}, year = {2019}, month = {September 2019}, pages = {1138-1142}, type = {Research Article}, chapter = {1138}, abstract = {

This research study evaluates the effect of Ocimum sanctum leaf extract on the entero-insular axis and the hyperglycemia due to oral glucose tolerance test in albino rats. Methanolic leaf extract of Ocimum sanctum was prepared by Sami labs, Bangalore and used for the study. After obtaining Institutional Animal ethical committee clearance male albino rats (155{\textendash}215 g) were divided into 4 groups. 6 albino rats were randomly assigned to Control (Normal saline) group, Standard (Vildagliptin 50 mg/kg) group, Ocimum sanctum leaf extract (100 mg/kg) and (200 mg/kg) groups. After overnight fasting the baseline biochemical evaluation in the fasting state blood glucose, Insulin level, Glucagon level, GLP-1 (Glucagon like peptide-1), GIP (Glucose dependent Insulinotropic peptide) level were measured for all the above groups. Control, Vildagliptin (STD) and the extracts were orally administered by using rat oral feeding tube. 30 minutes later oral glucose tolerance test (OGTT) was done. Blood samples were evaluated for blood sugar, Insulin, Glucagon, GLP-1 and GIP at 0, 15 and 45 minutes after oral glucose load. Ocimum sanctum (200 mg/kg) showed significant (p <= 0.05) reduction in blood glucose at 45 minutes when compared to control. Ocimum sanctum (100 mg/kg \& 200 mg/kg) showed significant (p <= 0.001) increase in GIP levels at 45 minutes of OGTT. Ocimum sanctum leaf extract showed significant antihyperglycemic and incretin enhancing effects. Further indepth animal and clinical studies are necessary to demonstrate the therapeutic potential of this extract for the treatment of type 2 diabetes mellitus.

}, keywords = {Antihyperglycemic, Entero-Insular axis, Glucagon, Insulin, Ocimum sanctum}, doi = {10.5530/pj.2019.11.177}, author = {Inbaraj SD and Muniappan M} }